US Broker Ratings

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Promising Biotech Pioneer with 63% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) has carved out a significant niche in the biotechnology sector by focusing on rare diseases, a strategy that has captured investor..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Unveiling a 340% Potential Upside for Bold Investors

Dyne Therapeutics, Inc. (NASDAQ: DYN) is emerging as a captivating opportunity within the biotechnology sector, boasting a remarkable 340% potential upside that has piqued the interest..

NewAmsterdam Pharma (NAMS) Stock Analysis: Strong Buy Ratings and an 86% Upside Potential

NewAmsterdam Pharma Company N.V. (NAMS), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline and substantial upside potential. Headquartered in..

Novavax, Inc. (NVAX): Investor Outlook on a Biotech Firm with 87% Upside Potential

Novavax, Inc. (NASDAQ: NVAX) is a notable player in the biotech sector, particularly as it continues its pioneering efforts in vaccine development. With a focus on..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 292.54% Upside Potential in the Biotechnology Sector

Biohaven Ltd. (BHVN) stands as a notable player in the biotechnology industry, with a market capitalization of $1.41 billion. Headquartered in New Haven, Connecticut, Biohaven is..

Arcutis Biotherapeutics (ARQT) Stock Analysis: A Deep Dive into Its 47.44% Potential Upside

In the vibrant arena of biotechnology, Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is attracting significant attention with its promising portfolio of dermatological treatments, coupled with a compelling..

Organon & Co. (OGN) Stock Analysis: Evaluating the 48% Potential Upside Amidst Current Challenges

Organon & Co. (NYSE: OGN) presents an intriguing opportunity for investors within the healthcare sector, particularly in the general drug manufacturing industry. With a significant market..

Dynavax Technologies (DVAX) Investor Outlook: Navigating a Promising 112.75% Upside Potential

Dynavax Technologies Corporation (NASDAQ: DVAX), a leading player in the healthcare sector, continues to captivate investor interest with its strong potential for future growth. With a..

Schrodinger, Inc. (SDGR) Stock Analysis: Exploring a 39.25% Potential Upside in Health Information Services

Schrodinger, Inc. (NASDAQ: SDGR) is capturing the attention of investors with a robust potential upside of 39.25%, according to current analyst ratings. Positioned squarely in the..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 17.36% Potential Upside in the CNS Market

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, operates within the niche of drug manufacturers specializing in both specialty and generic products. Based..

Addus HomeCare Corporation (ADUS) Stock Analysis: 27% Upside Potential Amid Robust Revenue Growth

Addus HomeCare Corporation (NASDAQ: ADUS), a key player in the healthcare sector, stands out with its promising financial metrics and growth prospects. With a market capitalization..

Ligand Pharmaceuticals (LGND): Investor Outlook on a Biotech Leader with a 46% Revenue Growth Surge

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a key player in the biotechnology sector, stands out with its robust portfolio of biopharmaceutical assets. The company, headquartered in Jupiter,..

Amedisys Inc (AMED) Stock Analysis: Navigating Valuation Metrics and Growth Potential in the Healthcare Sector

Amedisys Inc. (NASDAQ: AMED), a prominent player in the healthcare sector, operates in the medical care facilities industry, specializing in providing crucial home health, hospice, and..

Astrana Health Inc. (ASTH) Stock Analysis: A 105% Upside Potential Amidst Robust Revenue Growth

Astrana Health Inc. (NASDAQ: ASTH), a healthcare management company headquartered in Alhambra, California, is emerging as a compelling investment opportunity within the medical care facilities industry...

Teladoc Health, Inc. (TDOC) Investor Outlook: Navigating the Virtual Healthcare Landscape with a 7.73% Potential Upside

Teladoc Health, Inc. (NYSE: TDOC) is a key player in the burgeoning virtual healthcare sector, offering a range of integrated care solutions and mental health services..

Perrigo Company plc (PRGO) Investor Outlook: Exploring a 35% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is commanding attention with a..

Ascentage Pharma Group (AAPG) Stock Analysis: Navigating High Growth in Biotechnology with Significant Challenges

Ascentage Pharma Group International (NASDAQ: AAPG), a prominent player in the biotechnology sector, is making waves with its ambitious pipeline targeting cancers, chronic hepatitis B, and..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Navigating a 3.36% Potential Upside Amidst Healthcare Sector Dynamics

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, operates senior living communities across the United States. With a market capitalization of..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: A Biotech with 182.60% Potential Upside

Viking Therapeutics, Inc. (NASDAQ: VKTX), a clinical-stage biopharmaceutical company, has captured investor attention with its promising drug pipeline and significant upside potential. The company, based in..

PACS Group, Inc. (PACS) Stock Analysis: A 162% Upside Potential in Healthcare

PACS Group, Inc. (NASDAQ: PACS), a prominent player in the healthcare sector, is catching the eye of investors with a staggering potential upside of 162.48%. Operating..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds